Regional variation in antenatal corticosteroid use: a network-level quality improvement study

Pediatrics. 2015 Feb;135(2):e397-404. doi: 10.1542/peds.2014-2177. Epub 2015 Jan 19.

Abstract

Background and objectives: Examination of regional care patterns in antenatal corticosteroid use (ACU) rates may be salient for the development of targeted interventions. Our objective was to assess network-level variation using California perinatal care regions as a proxy. We hypothesized that (1) significant variation in ACU exists within and between California perinatal care regions, and (2) lower performing regions exhibit greater NICU-level variability in ACU than higher performing regions.

Methods: We undertook cross-sectional analysis of 33,610 very low birth weight infants cared for at 120 hospitals in 11 California perinatal care regions from 2005 to 2011. We computed risk-adjusted median ACU rates and interquartile ranges (IQR) for each perinatal care region. The degree of variation was assessed using hierarchical multivariate regression analysis with NICU as a random effect and region as a fixed effect.

Results: From 2005 to 2011, mean ACU rates across California increased from 82% to 87.9%. Regional median (IQR) ACU rates ranged from 68.4% (24.3) to 92.9% (4.8). We found significant variation in ACU rates among regions (P < .0001). Compared with Level IV NICUs, care in a lower level of care was a strongly significant predictor of lower odds of receiving antenatal corticosteroids in a multilevel model (Level III, 0.65 [0.45-0.95]; Level II, 0.39 [0.24-0.64]; P < .001). Regions with lower performance in ACU exhibited greater variability in performance.

Conclusions: We found significant variation in ACU rates among California perinatal regions. Regional quality improvement approaches may offer a new avenue to spread best practice.

Keywords: antenatal corticosteroids; neonatal intensive care; quality of care; variation.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenal Cortex Hormones / adverse effects
  • Adrenal Cortex Hormones / therapeutic use*
  • Adult
  • California
  • Drug Utilization / statistics & numerical data*
  • Female
  • Humans
  • Infant, Newborn
  • Infant, Very Low Birth Weight*
  • Intensive Care Units, Neonatal
  • Male
  • Maternal Age
  • Pregnancy
  • Prenatal Exposure Delayed Effects
  • Quality Assurance, Health Care
  • Quality Improvement*
  • Regional Medical Programs
  • Respiratory Distress Syndrome, Newborn / prevention & control*
  • Risk Factors
  • Topography, Medical
  • Young Adult

Substances

  • Adrenal Cortex Hormones

Supplementary concepts

  • Respiratory Distress Syndrome In Premature Infants